Ruben Rathnasingham, Ph.D.

Ruben Rathnasingham has more than 15 years of biomedical leadership experience in several companies founded on technologies invented and developed in academic institutions. At Dell Medical School, he is responsible for creating and growing initiatives to support health-related translational research at The University of Texas at Austin.

Most recently, he was associate director of early translational research at the University of California, San Francisco, where he helped develop and led the UCSF Catalyst Program that successfully leveraged industry partners to help identify, support and translate technologies through and out of the university. Prior to his tenure in academia, Rathnasingham co-founded and grew a number of health care companies, including StrataGent Life Sciences, where he helped develop a needle-free, wearable infusion pump that was honored with a 2010 Edison Award for Best New Product.